Director/PDMR Shareholding

RNS Number : 0951A
Immupharma PLC
02 June 2016
 

 

 

For Immediate Release                                                                                                                            2 June 2016

 

 

IMMUPHARMA PLC

Grant of Options

 

 

ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, has today granted a total number of 1,600,000 share options to certain of its directors and employees representing 1.31% of ImmuPharma's Ordinary Shares and total voting rights. The exercise price for these options is 43.88 pence being the closing middle market share price on 1 June 2016. The options are exercisable between three and ten years from the date of grant.

 

The Company has adopted a HM Revenue & Customs approved share ownership plan (CSOP) and an unapproved share option scheme.

 

The amount of options granted to directors are summarised in the following table:

 

Director

Options Granted

Tim McCarthy

500,000

Franco di Muzio

100,000

Stephane Mery

100,000

 

Following this grant of options, the total number of share options outstanding will be 3,080,000 representing 2.53% of ImmuPharma's total voting rights.

 

 

-Ends-

For further information please contact:

 

ImmuPharma plc (www.immupharma.org)

+ 44 (0) 20 7152 4080

Tim McCarthy, Chairman


Lisa Baderoon, Head of Investor Relations

Twitter: @immupharma

 

        + 44 (0) 7721 413 496

 

 

 

Panmure, Gordon & Co., NOMAD & Broker

 

+44 (0) 20 7886 2500

Fred Walsh, Duncan Monteith, Corporate Finance

Charles Leigh-Pemberton, Corporate Broking



 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHFTMFTMBTMBAF

Companies

Immupharma (IMM)
UK 100

Latest directors dealings